カテゴリー： 世界, 医療/バイオ, LP Information

世界の経口ボルデテラワクチン市場予測 2023年-2029年

【英語タイトル】Global Oral Bordetella Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC05414）・商品コード：LP23DC05414
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：78
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の経口ボルデテラワクチン市場」は、過去の販売実績から2022年の世界の経口ボルデテラワクチンの総販売量を検討し、2023年から2029年の予測される経口ボルデテラワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の経口ボルデテラワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の経口ボルデテラワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の経口ボルデテラワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の経口ボルデテラワクチン市場における各社の独自のポジションをより深く理解するために、経口ボルデテラワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の経口ボルデテラワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。経口ボルデテラワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。経口ボルデテラワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。経口ボルデテラワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

経口ボルデテラワクチンの世界主要メーカーとしては、Boehringer Ingelheim(Merial)、 Merck Animal Health、 Zoetis、 Elancoなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の経口ボルデテラワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では経口ボルデテラワクチン市場をセグメンテーションし、種類別 (混合ワクチン、ボルデテラワクチンのみ)、用途別 (子犬、成犬)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：混合ワクチン、ボルデテラワクチンのみ

・用途別区分：子犬、成犬

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の経口ボルデテラワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た経口ボルデテラワクチン市場成長の要因は何か？
・経口ボルデテラワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・経口ボルデテラワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：経口ボルデテラワクチンの年間販売量2018-2029、地域別現状・将来分析
・経口ボルデテラワクチンの種類別セグメント：混合ワクチン、ボルデテラワクチンのみ
・経口ボルデテラワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・経口ボルデテラワクチンの用途別セグメント：子犬、成犬
・経口ボルデテラワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の経口ボルデテラワクチン市場
・企業別のグローバル経口ボルデテラワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の経口ボルデテラワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の経口ボルデテラワクチン販売価格
・主要企業の経口ボルデテラワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

経口ボルデテラワクチンの地域別レビュー
・地域別の経口ボルデテラワクチン市場規模2018-2023：年間販売量、売上
・主要国別の経口ボルデテラワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの経口ボルデテラワクチン販売の成長
・アジア太平洋の経口ボルデテラワクチン販売の成長
・ヨーロッパの経口ボルデテラワクチン販売の成長
・中東・アフリカの経口ボルデテラワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の経口ボルデテラワクチン販売量、売上（2018-2023）
・南北アメリカの経口ボルデテラワクチンの種類別販売量
・南北アメリカの経口ボルデテラワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の経口ボルデテラワクチン販売量、売上（2018-2023）
・アジア太平洋の経口ボルデテラワクチンの種類別販売量
・アジア太平洋の経口ボルデテラワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の経口ボルデテラワクチン販売量、売上（2018-2023）
・ヨーロッパの経口ボルデテラワクチンの種類別販売量
・ヨーロッパの経口ボルデテラワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の経口ボルデテラワクチン販売量、売上（2018-2023）
・中東・アフリカの経口ボルデテラワクチンの種類別販売量
・中東・アフリカの経口ボルデテラワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・経口ボルデテラワクチンの製造コスト構造分析
・経口ボルデテラワクチンの製造プロセス分析
・経口ボルデテラワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・経口ボルデテラワクチンの主要なグローバル販売業者
・経口ボルデテラワクチンの主要なグローバル顧客

地域別の経口ボルデテラワクチン市場予測レビュー
・地域別の経口ボルデテラワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・経口ボルデテラワクチンの種類別市場規模予測
・経口ボルデテラワクチンの用途別市場規模予測

主要企業分析
Boehringer Ingelheim(Merial)、 Merck Animal Health、 Zoetis、 Elanco
・企業情報
・経口ボルデテラワクチン製品
・経口ボルデテラワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Oral Bordetella Vaccine market size is projected to grow from US$ 122.3 million in 2022 to US$ 446.7 million in 2029; it is expected to grow at a CAGR of 20.3% from 2023 to 2029.
United States market for Oral Bordetella Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oral Bordetella Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oral Bordetella Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oral Bordetella Vaccine players cover Boehringer Ingelheim(Merial), Merck Animal Health, Zoetis and Elanco, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Oral Bordetella Vaccine Industry Forecast” looks at past sales and reviews total world Oral Bordetella Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Bordetella Vaccine sales for 2023 through 2029. With Oral Bordetella Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Bordetella Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Oral Bordetella Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Bordetella Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Bordetella Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Bordetella Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Bordetella Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Bordetella Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Combination Vaccine
Only Bordetella Vaccine
Segmentation by application
Puppies
Adult Dogs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Elanco
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Bordetella Vaccine market?
What factors are driving Oral Bordetella Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Bordetella Vaccine market opportunities vary by end market size?
How does Oral Bordetella Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Bordetella Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oral Bordetella Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oral Bordetella Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Oral Bordetella Vaccine Segment by Type
2.2.1 Combination Vaccine
2.2.2 Only Bordetella Vaccine
2.3 Oral Bordetella Vaccine Sales by Type
2.3.1 Global Oral Bordetella Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Oral Bordetella Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oral Bordetella Vaccine Sale Price by Type (2018-2023)
2.4 Oral Bordetella Vaccine Segment by Application
2.4.1 Puppies
2.4.2 Adult Dogs
2.5 Oral Bordetella Vaccine Sales by Application
2.5.1 Global Oral Bordetella Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Oral Bordetella Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oral Bordetella Vaccine Sale Price by Application (2018-2023)
3 Global Oral Bordetella Vaccine by Company
3.1 Global Oral Bordetella Vaccine Breakdown Data by Company
3.1.1 Global Oral Bordetella Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Oral Bordetella Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Oral Bordetella Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Oral Bordetella Vaccine Revenue by Company (2018-2023)
3.2.2 Global Oral Bordetella Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Oral Bordetella Vaccine Sale Price by Company
3.4 Key Manufacturers Oral Bordetella Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Bordetella Vaccine Product Location Distribution
3.4.2 Players Oral Bordetella Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Bordetella Vaccine by Geographic Region
4.1 World Historic Oral Bordetella Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Oral Bordetella Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oral Bordetella Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral Bordetella Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Oral Bordetella Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oral Bordetella Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral Bordetella Vaccine Sales Growth
4.4 APAC Oral Bordetella Vaccine Sales Growth
4.5 Europe Oral Bordetella Vaccine Sales Growth
4.6 Middle East & Africa Oral Bordetella Vaccine Sales Growth
5 Americas
5.1 Americas Oral Bordetella Vaccine Sales by Country
5.1.1 Americas Oral Bordetella Vaccine Sales by Country (2018-2023)
5.1.2 Americas Oral Bordetella Vaccine Revenue by Country (2018-2023)
5.2 Americas Oral Bordetella Vaccine Sales by Type
5.3 Americas Oral Bordetella Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Bordetella Vaccine Sales by Region
6.1.1 APAC Oral Bordetella Vaccine Sales by Region (2018-2023)
6.1.2 APAC Oral Bordetella Vaccine Revenue by Region (2018-2023)
6.2 APAC Oral Bordetella Vaccine Sales by Type
6.3 APAC Oral Bordetella Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Bordetella Vaccine by Country
7.1.1 Europe Oral Bordetella Vaccine Sales by Country (2018-2023)
7.1.2 Europe Oral Bordetella Vaccine Revenue by Country (2018-2023)
7.2 Europe Oral Bordetella Vaccine Sales by Type
7.3 Europe Oral Bordetella Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Bordetella Vaccine by Country
8.1.1 Middle East & Africa Oral Bordetella Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oral Bordetella Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral Bordetella Vaccine Sales by Type
8.3 Middle East & Africa Oral Bordetella Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Bordetella Vaccine
10.3 Manufacturing Process Analysis of Oral Bordetella Vaccine
10.4 Industry Chain Structure of Oral Bordetella Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Bordetella Vaccine Distributors
11.3 Oral Bordetella Vaccine Customer
12 World Forecast Review for Oral Bordetella Vaccine by Geographic Region
12.1 Global Oral Bordetella Vaccine Market Size Forecast by Region
12.1.1 Global Oral Bordetella Vaccine Forecast by Region (2024-2029)
12.1.2 Global Oral Bordetella Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Bordetella Vaccine Forecast by Type
12.7 Global Oral Bordetella Vaccine Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim(Merial)
13.1.1 Boehringer Ingelheim(Merial) Company Information
13.1.2 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim(Merial) Main Business Overview
13.1.5 Boehringer Ingelheim(Merial) Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Oral Bordetella Vaccine Product Portfolios and Specifications
13.2.3 Merck Animal Health Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Oral Bordetella Vaccine Product Portfolios and Specifications
13.3.3 Zoetis Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Oral Bordetella Vaccine Product Portfolios and Specifications
13.4.3 Elanco Oral Bordetella Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Oral Bordetella Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral Bordetella Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Combination Vaccine
Table 4. Major Players of Only Bordetella Vaccine
Table 5. Global Oral Bordetella Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Oral Bordetella Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Oral Bordetella Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oral Bordetella Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Oral Bordetella Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oral Bordetella Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Oral Bordetella Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Oral Bordetella Vaccine Revenue by Application (2018-2023)
Table 13. Global Oral Bordetella Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Oral Bordetella Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Oral Bordetella Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Oral Bordetella Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Oral Bordetella Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oral Bordetella Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Oral Bordetella Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Oral Bordetella Vaccine Producing Area Distribution and Sales Area
Table 21. Players Oral Bordetella Vaccine Products Offered
Table 22. Oral Bordetella Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral Bordetella Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Oral Bordetella Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oral Bordetella Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oral Bordetella Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oral Bordetella Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Oral Bordetella Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oral Bordetella Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oral Bordetella Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oral Bordetella Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Oral Bordetella Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Oral Bordetella Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oral Bordetella Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Oral Bordetella Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Oral Bordetella Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Oral Bordetella Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Oral Bordetella Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Oral Bordetella Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oral Bordetella Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Oral Bordetella Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Oral Bordetella Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Oral Bordetella Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Oral Bordetella Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Oral Bordetella Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oral Bordetella Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Oral Bordetella Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Oral Bordetella Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Oral Bordetella Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Oral Bordetella Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oral Bordetella Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oral Bordetella Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oral Bordetella Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Oral Bordetella Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Oral Bordetella Vaccine
Table 58. Key Market Challenges & Risks of Oral Bordetella Vaccine
Table 59. Key Industry Trends of Oral Bordetella Vaccine
Table 60. Oral Bordetella Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oral Bordetella Vaccine Distributors List
Table 63. Oral Bordetella Vaccine Customer List
Table 64. Global Oral Bordetella Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Oral Bordetella Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oral Bordetella Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Oral Bordetella Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oral Bordetella Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Oral Bordetella Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oral Bordetella Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Oral Bordetella Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oral Bordetella Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Oral Bordetella Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oral Bordetella Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Oral Bordetella Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oral Bordetella Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Oral Bordetella Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim(Merial) Basic Information, Oral Bordetella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolios and Specifications
Table 80. Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim(Merial) Main Business
Table 82. Boehringer Ingelheim(Merial) Latest Developments
Table 83. Merck Animal Health Basic Information, Oral Bordetella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Animal Health Oral Bordetella Vaccine Product Portfolios and Specifications
Table 85. Merck Animal Health Oral Bordetella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Animal Health Main Business
Table 87. Merck Animal Health Latest Developments
Table 88. Zoetis Basic Information, Oral Bordetella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Oral Bordetella Vaccine Product Portfolios and Specifications
Table 90. Zoetis Oral Bordetella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Elanco Basic Information, Oral Bordetella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Oral Bordetella Vaccine Product Portfolios and Specifications
Table 95. Elanco Oral Bordetella Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Elanco Main Business
Table 97. Elanco Latest Developments
List of Figures
Figure 1. Picture of Oral Bordetella Vaccine
Figure 2. Oral Bordetella Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Bordetella Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral Bordetella Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral Bordetella Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Combination Vaccine
Figure 10. Product Picture of Only Bordetella Vaccine
Figure 11. Global Oral Bordetella Vaccine Sales Market Share by Type in 2022
Figure 12. Global Oral Bordetella Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Oral Bordetella Vaccine Consumed in Puppies
Figure 14. Global Oral Bordetella Vaccine Market: Puppies (2018-2023) & (K Units)
Figure 15. Oral Bordetella Vaccine Consumed in Adult Dogs
Figure 16. Global Oral Bordetella Vaccine Market: Adult Dogs (2018-2023) & (K Units)
Figure 17. Global Oral Bordetella Vaccine Sales Market Share by Application (2022)
Figure 18. Global Oral Bordetella Vaccine Revenue Market Share by Application in 2022
Figure 19. Oral Bordetella Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Oral Bordetella Vaccine Sales Market Share by Company in 2022
Figure 21. Oral Bordetella Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Oral Bordetella Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Oral Bordetella Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Oral Bordetella Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Oral Bordetella Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Oral Bordetella Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Oral Bordetella Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Oral Bordetella Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Oral Bordetella Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Oral Bordetella Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Oral Bordetella Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Oral Bordetella Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Oral Bordetella Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Oral Bordetella Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Oral Bordetella Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Oral Bordetella Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Oral Bordetella Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Oral Bordetella Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Oral Bordetella Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Oral Bordetella Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Oral Bordetella Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Oral Bordetella Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Oral Bordetella Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Oral Bordetella Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Oral Bordetella Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Oral Bordetella Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Oral Bordetella Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Oral Bordetella Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Oral Bordetella Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Oral Bordetella Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Oral Bordetella Vaccine
Figure 72. Industry Chain Structure of Oral Bordetella Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Oral Bordetella Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Oral Bordetella Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Oral Bordetella Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Oral Bordetella Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Oral Bordetella Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Oral Bordetella Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の経口ボルデテラワクチン市場予測 2023年-2029年] (コード：LP23DC05414)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経口ボルデテラワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の犬用ボルデテラワクチン市場予測 2023年-2029年
  • 世界の経口腸チフスワクチン市場予測 2023年-2029年
  • 世界の経口狂犬病ワクチン市場予測 2023年-2029年
  • 世界のヒト用経口ワクチン市場予測 2023年-2029年
  • 世界の経口ワクチン接種市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆